RISK CHARACTERIZATION: PRINCIPLES AND PRACTICE

By Williams Pamela R. D.   Paustenbach Dennis J.  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 5, Iss. 4, 2002-10 ,pp. : 337-406

Taylor & Francis Ltd

Access to resources Recommend Favorite

SYMPOSIUM ON PHARMACOKINETICS PHARMACODYNAMICS IN THE DEVELOPING SYSTEM AND IMPACT ON RISK ASSESSMENT EXECUTIVE SUMMARY

By Young John F   Schwetz Bernard A   Willhite Calvin C   Kacew Sam  

Journal of Toxicology and Environmental Health, Vol. 49, Iss. 4, 1996-11 ,pp. : 339-356

Taylor & Francis Ltd

Access to resources Recommend Favorite

METHYL BROMIDE RISK CHARACTERIZATION IN CALIFORNIA

By Wedge Roberta M.   Abt Eileen N.   Hobbs Charles H.  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 4, Iss. 3, 2001-07 ,pp. : 333-339

Taylor & Francis Ltd

Access to resources Recommend Favorite

A RISK CHARACTERIZATION FOR ATRAZINE: ONCOGENICITY PROFILE

By Stevens James T.   Breckenridge Charles B.   Wetzel Larry   Thakur Ajit K.   Liu Cynthia   Werner Christoph   Luempert Louis G.   Eldridge J. Charles  

Journal of Toxicology and Environmental Health, Vol. 56, Iss. 2, 1999-01 ,pp. : 69-109

Taylor & Francis Ltd

Access to resources Recommend Favorite

Endocrine Disruptor Risk Characterization: An EPA Perspective

By Fenner-Crisp P.A.  

Regulatory Toxicology and Pharmacology, Vol. 26, Iss. 1, 1997-08 ,pp. : 70-73

Academic Press

Access to resources Recommend Favorite